| Florian Georg Huber, MD | |
|
111 Davis St, Salisbury, MD 21804-5032 | |
| (410) 749-4154 | |
| (410) 860-9583 |
| Full Name | Florian Georg Huber |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 111 Davis St, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144487760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | D0067577 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Home Care, Llc | Salisbury, MD | Home health agency |
| Amedisys Home Health | Salisbury, MD | Home health agency |
| Peninsula Regional Medical Center | Salisbury, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peninsula Orthopaedic Assoc., Pa | 6406844406 | 41 |
News Archive
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company's investigational fully personalized immunotherapy for HIV.
One of the goals of the European Research Council, ERC, is to bring the world's leading researchers to work in Europe. American Juleen Zierath is one of those who have received funds from the ERC. She found the best environment for her research at Karolinska Institutet in Sweden.
A targeted approach to treating toxoplasmosis, a parasitic disease, shows early promise in test-tube and animal studies, where it prevented the parasites from making selected proteins. When tested in newly infected mice, it reduced the number of viable parasites by more than 90 percent, researchers from the University of Chicago Medicine report in the Proceedings of the National Academy of Sciences.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
› Verified 1 days ago
| Entity Name | Peninsula Orthopaedic Assoc., Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811188766 PECOS PAC ID: 6406844406 Enrollment ID: O20040505001828 |
News Archive
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company's investigational fully personalized immunotherapy for HIV.
One of the goals of the European Research Council, ERC, is to bring the world's leading researchers to work in Europe. American Juleen Zierath is one of those who have received funds from the ERC. She found the best environment for her research at Karolinska Institutet in Sweden.
A targeted approach to treating toxoplasmosis, a parasitic disease, shows early promise in test-tube and animal studies, where it prevented the parasites from making selected proteins. When tested in newly infected mice, it reduced the number of viable parasites by more than 90 percent, researchers from the University of Chicago Medicine report in the Proceedings of the National Academy of Sciences.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Florian Georg Huber, MD 111 Davis St, Salisbury, MD 21804-5032 Ph: (410) 749-4154 | Florian Georg Huber, MD 111 Davis St, Salisbury, MD 21804-5032 Ph: (410) 749-4154 |
News Archive
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company's investigational fully personalized immunotherapy for HIV.
One of the goals of the European Research Council, ERC, is to bring the world's leading researchers to work in Europe. American Juleen Zierath is one of those who have received funds from the ERC. She found the best environment for her research at Karolinska Institutet in Sweden.
A targeted approach to treating toxoplasmosis, a parasitic disease, shows early promise in test-tube and animal studies, where it prevented the parasites from making selected proteins. When tested in newly infected mice, it reduced the number of viable parasites by more than 90 percent, researchers from the University of Chicago Medicine report in the Proceedings of the National Academy of Sciences.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
› Verified 1 days ago
Dr. James Andrew Trauger, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Drive, Salisbury, MD 21804 Phone: 410-749-4154 Fax: 410-860-9583 | |
Dr. Pasquale Petrera, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Drive, Salisbury, MD 21804 Phone: 410-749-4154 Fax: 410-860-9583 | |
Dr. Patrick Andrew Holt, M.D., PH.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-749-4154 | |
Dr. Taylor Joseph Wiley, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-749-4154 | |
Dr. Anthony John Adrignolo Iii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-749-4154 Fax: 410-860-9583 | |
Dr. Jason Matthew Scopp, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Woodbrooke Drive, Salisbury, MD 21804 Phone: 410-749-4154 Fax: 410-860-9583 |